515 related articles for article (PubMed ID: 33065281)
1. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
[TBL] [Abstract][Full Text] [Related]
2. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
3. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
4. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD.
Fang MY; Markmiller S; Vu AQ; Javaherian A; Dowdle WE; Jolivet P; Bushway PJ; Castello NA; Baral A; Chan MY; Linsley JW; Linsley D; Mercola M; Finkbeiner S; Lecuyer E; Lewcock JW; Yeo GW
Neuron; 2019 Sep; 103(5):802-819.e11. PubMed ID: 31272829
[TBL] [Abstract][Full Text] [Related]
5. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
6. Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse.
Bjorklund GR; Wong J; Brafman D; Bowser R; Stabenfeldt SE
Acta Neuropathol Commun; 2023 Aug; 11(1):137. PubMed ID: 37608352
[TBL] [Abstract][Full Text] [Related]
7. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
[TBL] [Abstract][Full Text] [Related]
8. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
[TBL] [Abstract][Full Text] [Related]
9. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.
Ke YD; van Hummel A; Au C; Chan G; Lee WS; van der Hoven J; Przybyla M; Deng Y; Sabale M; Morey N; Bertz J; Feiten A; Ippati S; Stevens CH; Yang S; Gladbach A; Haass NK; Kril JJ; Blair IP; Delerue F; Ittner LM
Neuron; 2024 Apr; 112(8):1249-1264.e8. PubMed ID: 38366598
[TBL] [Abstract][Full Text] [Related]
10. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
[TBL] [Abstract][Full Text] [Related]
11. S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.
Pirie E; Oh CK; Zhang X; Han X; Cieplak P; Scott HR; Deal AK; Ghatak S; Martinez FJ; Yeo GW; Yates JR; Nakamura T; Lipton SA
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33692125
[TBL] [Abstract][Full Text] [Related]
12. Modulating ALS-Related Amyloidogenic TDP-43
Laos V; Bishop D; Lang CA; Marsh NM; Cantrell KL; Buratto SK; Singh AK; Bowers MT
Biochemistry; 2020 Feb; 59(4):499-508. PubMed ID: 31846303
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.
Sidibé H; Khalfallah Y; Xiao S; Gómez NB; Fakim H; Tank EMH; Di Tomasso G; Bareke E; Aulas A; McKeever PM; Melamed Z; Destroimaisons L; Deshaies JE; Zinman L; Parker JA; Legault P; Tétreault M; Barmada SJ; Robertson J; Vande Velde C
Brain; 2021 Dec; 144(11):3461-3476. PubMed ID: 34115105
[TBL] [Abstract][Full Text] [Related]
14. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
[TBL] [Abstract][Full Text] [Related]
15. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
16. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
17. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Vanden Broeck L; Callaerts P; Dermaut B
Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Bright F; Chan G; van Hummel A; Ittner LM; Ke YD
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360544
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
Afroz T; Chevalier E; Audrain M; Dumayne C; Ziehm T; Moser R; Egesipe AL; Mottier L; Ratnam M; Neumann M; Havas D; Ollier R; Piorkowska K; Chauhan M; Silva AB; Thapa S; Stöhr J; Bavdek A; Eligert V; Adolfsson O; Nelson PT; Porta S; Lee VM; Pfeifer A; Kosco-Vilbois M; Seredenina T
Neurobiol Dis; 2023 Apr; 179():106050. PubMed ID: 36809847
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.
Bourbouli M; Rentzos M; Bougea A; Zouvelou V; Constantinides VC; Zaganas I; Evdokimidis I; Kapaki E; Paraskevas GP
Dement Geriatr Cogn Disord; 2017; 44(3-4):144-152. PubMed ID: 28848086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]